The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation: An in vivo study in streptozotocin-induced diabetic mouse

Kai Chiang Yang, Zhi Qi, Chang Chin Wu, Yasumasa Shirouza, Feng Huei Lin, Goichi Yanai, Shoichiro Sumi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Immune rejection and scarcity of donor tissues are the restrictions of islets transplantation. In this study, the cytoprotection of chitosan hydrogels in xenogeneic islet transplantation was demonstrated. Wistar rat islets encapsulated in chitosan hydrogels were performed glucose challenge test and live/dead cell staining in vitro. Islets/chitosan hydrogels were transplanted into the renal subcapsular space of diabetic C57BL/6 mice. Non-fasting blood glucose level (NFBG), body weight, intraperitoneal glucose tolerance test (IPGTT), and glucose disappearance rate were determined perioperatively. The serum insulin level was analyzed, and the kidney transplanted with islets/chitosan hydrogels were retrieved for histological examination after sacrifice. The present results showed that islets encapsulated in chitosan hydrogels secreted insulin in response to the glucose stimulation as naked islets with higher cell survival. The NFBG of diabetic mice transplanted with islets/chitosan hydrogels decreased from 487 ± 46 to 148 ± 32 at one day postoperation and maintained in the range of 201 ± 36 mg/dl for four weeks with an increase in body weight. IPGTT showed the glucose disappearance rate of mice transplanted with islets/chitosan hydrogels was significant faster than that of mice transplanted with naked islets; the serum insulin level increased from 0.29 ± 0.06 to 1.69 ± 0.65 μg/dl postoperatively. Histological examination revealed that the islets successfully engrafted at renal subcapsular space with positive insulin staining. The immunostain was negative for neither the T-cell lineages nor the monocyte/macrophages. This study indicates that the chitosan hydrogels deliver and protect encapsulated islets successfully in xenotransplantation.

Original languageEnglish
Pages (from-to)818-823
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume393
Issue number4
DOIs
Publication statusPublished - Mar 19 2010
Externally publishedYes

Fingerprint

Islets of Langerhans Transplantation
Hydrogels
Cytoprotection
Chitosan
Streptozocin
Glucose
Insulin
Glucose Tolerance Test
Kidney
Blood Glucose
Body Weight
Staining and Labeling
Heterologous Transplantation
T-cells
Macrophages
Cell Lineage
Serum
Inbred C57BL Mouse
Wistar Rats
Rats

Keywords

  • Chitosan
  • Encapsulation
  • Hydrogels
  • Type 1 diabetes
  • Xenotransplantation

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation : An in vivo study in streptozotocin-induced diabetic mouse. / Yang, Kai Chiang; Qi, Zhi; Wu, Chang Chin; Shirouza, Yasumasa; Lin, Feng Huei; Yanai, Goichi; Sumi, Shoichiro.

In: Biochemical and Biophysical Research Communications, Vol. 393, No. 4, 19.03.2010, p. 818-823.

Research output: Contribution to journalArticle

Yang, Kai Chiang ; Qi, Zhi ; Wu, Chang Chin ; Shirouza, Yasumasa ; Lin, Feng Huei ; Yanai, Goichi ; Sumi, Shoichiro. / The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation : An in vivo study in streptozotocin-induced diabetic mouse. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 393, No. 4. pp. 818-823.
@article{9f527e14afe8447a9aed01fd4d1c556e,
title = "The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation: An in vivo study in streptozotocin-induced diabetic mouse",
abstract = "Immune rejection and scarcity of donor tissues are the restrictions of islets transplantation. In this study, the cytoprotection of chitosan hydrogels in xenogeneic islet transplantation was demonstrated. Wistar rat islets encapsulated in chitosan hydrogels were performed glucose challenge test and live/dead cell staining in vitro. Islets/chitosan hydrogels were transplanted into the renal subcapsular space of diabetic C57BL/6 mice. Non-fasting blood glucose level (NFBG), body weight, intraperitoneal glucose tolerance test (IPGTT), and glucose disappearance rate were determined perioperatively. The serum insulin level was analyzed, and the kidney transplanted with islets/chitosan hydrogels were retrieved for histological examination after sacrifice. The present results showed that islets encapsulated in chitosan hydrogels secreted insulin in response to the glucose stimulation as naked islets with higher cell survival. The NFBG of diabetic mice transplanted with islets/chitosan hydrogels decreased from 487 ± 46 to 148 ± 32 at one day postoperation and maintained in the range of 201 ± 36 mg/dl for four weeks with an increase in body weight. IPGTT showed the glucose disappearance rate of mice transplanted with islets/chitosan hydrogels was significant faster than that of mice transplanted with naked islets; the serum insulin level increased from 0.29 ± 0.06 to 1.69 ± 0.65 μg/dl postoperatively. Histological examination revealed that the islets successfully engrafted at renal subcapsular space with positive insulin staining. The immunostain was negative for neither the T-cell lineages nor the monocyte/macrophages. This study indicates that the chitosan hydrogels deliver and protect encapsulated islets successfully in xenotransplantation.",
keywords = "Chitosan, Encapsulation, Hydrogels, Type 1 diabetes, Xenotransplantation",
author = "Yang, {Kai Chiang} and Zhi Qi and Wu, {Chang Chin} and Yasumasa Shirouza and Lin, {Feng Huei} and Goichi Yanai and Shoichiro Sumi",
year = "2010",
month = "3",
day = "19",
doi = "10.1016/j.bbrc.2010.02.089",
language = "English",
volume = "393",
pages = "818--823",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "4",

}

TY - JOUR

T1 - The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation

T2 - An in vivo study in streptozotocin-induced diabetic mouse

AU - Yang, Kai Chiang

AU - Qi, Zhi

AU - Wu, Chang Chin

AU - Shirouza, Yasumasa

AU - Lin, Feng Huei

AU - Yanai, Goichi

AU - Sumi, Shoichiro

PY - 2010/3/19

Y1 - 2010/3/19

N2 - Immune rejection and scarcity of donor tissues are the restrictions of islets transplantation. In this study, the cytoprotection of chitosan hydrogels in xenogeneic islet transplantation was demonstrated. Wistar rat islets encapsulated in chitosan hydrogels were performed glucose challenge test and live/dead cell staining in vitro. Islets/chitosan hydrogels were transplanted into the renal subcapsular space of diabetic C57BL/6 mice. Non-fasting blood glucose level (NFBG), body weight, intraperitoneal glucose tolerance test (IPGTT), and glucose disappearance rate were determined perioperatively. The serum insulin level was analyzed, and the kidney transplanted with islets/chitosan hydrogels were retrieved for histological examination after sacrifice. The present results showed that islets encapsulated in chitosan hydrogels secreted insulin in response to the glucose stimulation as naked islets with higher cell survival. The NFBG of diabetic mice transplanted with islets/chitosan hydrogels decreased from 487 ± 46 to 148 ± 32 at one day postoperation and maintained in the range of 201 ± 36 mg/dl for four weeks with an increase in body weight. IPGTT showed the glucose disappearance rate of mice transplanted with islets/chitosan hydrogels was significant faster than that of mice transplanted with naked islets; the serum insulin level increased from 0.29 ± 0.06 to 1.69 ± 0.65 μg/dl postoperatively. Histological examination revealed that the islets successfully engrafted at renal subcapsular space with positive insulin staining. The immunostain was negative for neither the T-cell lineages nor the monocyte/macrophages. This study indicates that the chitosan hydrogels deliver and protect encapsulated islets successfully in xenotransplantation.

AB - Immune rejection and scarcity of donor tissues are the restrictions of islets transplantation. In this study, the cytoprotection of chitosan hydrogels in xenogeneic islet transplantation was demonstrated. Wistar rat islets encapsulated in chitosan hydrogels were performed glucose challenge test and live/dead cell staining in vitro. Islets/chitosan hydrogels were transplanted into the renal subcapsular space of diabetic C57BL/6 mice. Non-fasting blood glucose level (NFBG), body weight, intraperitoneal glucose tolerance test (IPGTT), and glucose disappearance rate were determined perioperatively. The serum insulin level was analyzed, and the kidney transplanted with islets/chitosan hydrogels were retrieved for histological examination after sacrifice. The present results showed that islets encapsulated in chitosan hydrogels secreted insulin in response to the glucose stimulation as naked islets with higher cell survival. The NFBG of diabetic mice transplanted with islets/chitosan hydrogels decreased from 487 ± 46 to 148 ± 32 at one day postoperation and maintained in the range of 201 ± 36 mg/dl for four weeks with an increase in body weight. IPGTT showed the glucose disappearance rate of mice transplanted with islets/chitosan hydrogels was significant faster than that of mice transplanted with naked islets; the serum insulin level increased from 0.29 ± 0.06 to 1.69 ± 0.65 μg/dl postoperatively. Histological examination revealed that the islets successfully engrafted at renal subcapsular space with positive insulin staining. The immunostain was negative for neither the T-cell lineages nor the monocyte/macrophages. This study indicates that the chitosan hydrogels deliver and protect encapsulated islets successfully in xenotransplantation.

KW - Chitosan

KW - Encapsulation

KW - Hydrogels

KW - Type 1 diabetes

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=77949658807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949658807&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.02.089

DO - 10.1016/j.bbrc.2010.02.089

M3 - Article

C2 - 20171166

AN - SCOPUS:77949658807

VL - 393

SP - 818

EP - 823

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -